Smartphone app aims to predict and prevent COPD attacks using weather data
NCT ID NCT07656142
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized mobile app that gives temperature-related health warnings and safety tips can reduce acute exacerbations (sudden worsening of symptoms) in people with chronic obstructive pulmonary disease (COPD). About 240 participants will either receive the app plus usual care or usual care alone. The main goal is to see if the app lowers the number of COPD flare-ups over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- personalized mobile application with temperature-related health risk warnings
- What this could lead to
- If effective, this app could help people with COPD avoid acute exacerbations triggered by temperature changes, improving daily life and reducing hospital visits.
- What could go wrong
- This is a relatively small trial testing a behavioral intervention, not a drug. Results may vary based on user engagement, and the app may not work for everyone or in all climates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD